In August, 5 Vaping Brands Raised Over 200 Million Yuan
Since the beginning of August, at least five vaping brands—including Gippro, WIPPO, Yinwei, Yishuang, and KMOSE—have secured funding, with total financing exceeding 200 million yuan.
In fact, since the start of August, quite a few brands in the e-cigarette industry have already secured funding. According to the author’s incomplete statistics, in just the first 20 days of August, at least five brands received financing: Gippro, WIPPO, Yinwei, Yishuang, and KMOSE.
Among them, Gippro secured 50 million yuan in financing, WIPPO received a first-round investment worth tens of millions of yuan from an industry supply-chain capital source, Yinwei completed a 100 million yuan financing round, KMOSE completed an angel round worth tens of millions of yuan, and Yishuang established a joint venture subsidiary with Xiong’an Technology. Combined, the five e-cigarette brands raised more than 200 million yuan.
Yishuang e-cigarettes and Xiong’an Technology establish a 100 million yuan joint venture
On August 14, Xiong’an Technology and Shenzhen Yishuang entered into a strategic cooperation framework agreement. The two parties plan to establish a joint venture in Hong Kong to expand their e-cigarette business into overseas markets. The registered capital of the joint venture will not exceed 100 million yuan, with each side holding a 50% stake.
WIPPO receives a 10 million yuan Series A investment
According to news released on August 14, WIPPO secured a 10 million yuan Series A investment. As a rising player in the e-cigarette sector, WIPPO received a first-round investment worth tens of millions of yuan from an industry supply-chain capital source. The funds will continue to be used for product R&D, support for channels with high-frequency consumption scenarios, and expansion into overseas markets such as Southeast Asia.
KMOSE completes angel financing worth tens of millions of yuan
According to media reports, e-cigarette brand KMOSE recently announced the completion of an angel financing round worth tens of millions of yuan. KMOSE co-founder and CEO Liu Haonan said the funding will mainly be used for KMOSE product R&D and production, as well as channel development and channel branding.
Gippro secures 50 million yuan investment from Meiri Health
On August 6, Meiri Health International (02327.HK) announced that it had signed a strategic cooperation memorandum with GIPPRO Japan. Based on both parties’ optimism about the application of atomization technology in the health sector, as well as the policy environment and market prospects for cannabidiol in Japan, the two sides will establish a joint venture in Japan to strengthen R&D on atomization technology for health-related ingredients such as cannabidiol, along with the branding, operation, and sales of related vaporization products.
Meiri Health plans to invest 50 million yuan for a 10% stake in Gippro Group, while the two parties will also jointly establish a Japan operating company that will be independently responsible for development and operations in the Japanese market. Meiri Health will hold 51% of that company’s equity. This implies a valuation of 500 million yuan for Gippro Group. In July 2018, Gippro had previously announced the completion of an angel round worth tens of millions of yuan, with Tongchuang Weiye, a private equity investment institution, as the investor.
Yinwei completes 100 million yuan financing
On August 3, new e-cigarette brand Yinwei held a launch event in Beijing to debut its new disposable vaping device, while also announcing the completion of a 100 million yuan financing round, although the specific investors were not disclosed.
Among them, Gippro secured 50 million yuan in financing, WIPPO received a first-round investment worth tens of millions of yuan from an industry supply-chain capital source, Yinwei completed a 100 million yuan financing round, KMOSE completed an angel round worth tens of millions of yuan, and Yishuang established a joint venture subsidiary with Xiong’an Technology. Combined, the five e-cigarette brands raised more than 200 million yuan.
Yishuang e-cigarettes and Xiong’an Technology establish a 100 million yuan joint venture
On August 14, Xiong’an Technology and Shenzhen Yishuang entered into a strategic cooperation framework agreement. The two parties plan to establish a joint venture in Hong Kong to expand their e-cigarette business into overseas markets. The registered capital of the joint venture will not exceed 100 million yuan, with each side holding a 50% stake.
WIPPO receives a 10 million yuan Series A investment
According to news released on August 14, WIPPO secured a 10 million yuan Series A investment. As a rising player in the e-cigarette sector, WIPPO received a first-round investment worth tens of millions of yuan from an industry supply-chain capital source. The funds will continue to be used for product R&D, support for channels with high-frequency consumption scenarios, and expansion into overseas markets such as Southeast Asia.
KMOSE completes angel financing worth tens of millions of yuan
According to media reports, e-cigarette brand KMOSE recently announced the completion of an angel financing round worth tens of millions of yuan. KMOSE co-founder and CEO Liu Haonan said the funding will mainly be used for KMOSE product R&D and production, as well as channel development and channel branding.
Gippro secures 50 million yuan investment from Meiri Health
On August 6, Meiri Health International (02327.HK) announced that it had signed a strategic cooperation memorandum with GIPPRO Japan. Based on both parties’ optimism about the application of atomization technology in the health sector, as well as the policy environment and market prospects for cannabidiol in Japan, the two sides will establish a joint venture in Japan to strengthen R&D on atomization technology for health-related ingredients such as cannabidiol, along with the branding, operation, and sales of related vaporization products.
Meiri Health plans to invest 50 million yuan for a 10% stake in Gippro Group, while the two parties will also jointly establish a Japan operating company that will be independently responsible for development and operations in the Japanese market. Meiri Health will hold 51% of that company’s equity. This implies a valuation of 500 million yuan for Gippro Group. In July 2018, Gippro had previously announced the completion of an angel round worth tens of millions of yuan, with Tongchuang Weiye, a private equity investment institution, as the investor.
Yinwei completes 100 million yuan financing
On August 3, new e-cigarette brand Yinwei held a launch event in Beijing to debut its new disposable vaping device, while also announcing the completion of a 100 million yuan financing round, although the specific investors were not disclosed.



